Elicio Therapeutics

(NASDAQ) ELTX

Current Price$3.40

Market Cap$98.10M

Since IPO (2023)-78%

5 Year-96%

1 Year-33%

1 Month-58%

Elicio Therapeutics Financials at a Glance

Market Cap

$98.10M

Revenue (TTM)

$0.00

Net Income (TTM)

-$40.19M

EPS (TTM)

-$2.34

P/E Ratio

-2.19

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$3.40

Volume

2,317,616.063

Open

$3.60

Price

$3.40

Volume

2,317,616.063

Open

$3.60

Previous Close

$5.14

Daily Range

$3.42 - $3.80

52-Week Range

$2.66 - $16.00

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$3.40

Volume

2,317,616.063

Open

$3.60

Previous Close

$5.14

Daily Range

$3.42 - $3.80

52-Week Range

$2.66 - $16.00

Estimated Earnings Date

Aug 6, 2026

ELTX News

Elicio (ELTX) Q2 Loss Beats Estimates

Motley Fool Markets TeamAug 7, 2025

ELTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elicio Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Robert T. Connelly

Website

www.elicio.com

Headquarters

Boston, MA 02210, US

ELTX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-2748.16%

Return on Capital

-233.55%

Return on Assets

-177.11%

Earnings Yield

-45.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$98.10M

Shares Outstanding

19.09M

Volume

2.32M

Avg. Volume

1.43M

Financials (TTM)

Gross Profit

-$289.00K

Operating Income

-$37.58M

EBITDA

-$37.68M

Operating Cash Flow

-$38.48M

Capital Expenditure

-$16.00K

Free Cash Flow

-$38.49M

Cash & ST Invst.

$14.95M

Total Debt

$14.34M

Elicio Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$289.00K

-4.0%

Gross Margin

0.00%

N/A

Market Cap

$98.10M

N/A

Market Cap/Employee

$3.07M

N/A

Employees

N/A

Net Income

-$11.82M

-5.5%

EBITDA

-$11.13M

-3.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$14.95M

-18.5%

Total Debt

$14.34M

+147.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$13.30M

+173.3%

Short Term Debt

$1.04M

+12.5%

Return on Assets

-1.77%

N/A

Return on Invested Capital

-2.43%

N/A

Free Cash Flow

-$11.65M

-15.1%

Operating Cash Flow

-$11.65M

-15.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.27-1.94%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.33+0.76%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$9.47+4.36%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.84+1.38%

SAVACassava Sciences, Inc.

SAVACassava Sciences, Inc.$1.32+2.33%

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$0.79+2.77%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.10+4.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.13-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.02+0.03%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.97-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.44+0.02%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$12.80+0.05%

SMCISuper Micro Computer

SMCISuper Micro Computer$27.67+0.00%

TAT&T

TAT&T$20.54+0.00%

Questions About ELTX

What is the current price of Elicio Therapeutics?

Elicio Therapeutics is trading at $3.42 per share.

What is the 52-week range for Elicio Therapeutics?

Over the past 52 weeks, Elicio Therapeutics has traded between $2.66 and $16.00.

How much debt does Elicio Therapeutics have?

As of the most recent reporting period, Elicio Therapeutics reported total debt of $14.34M.

How much cash does Elicio Therapeutics have on hand?

Elicio Therapeutics reported $14.95M in cash and cash equivalents in its most recent financial results.

What is Elicio Therapeutics’s dividend yield?

Elicio Therapeutics does not currently have a dividend yield.

Elicio Therapeutics

Elicio Therapeutics Financials at a Glance

ELTX News

Elicio (ELTX) Q2 Loss Beats Estimates

ELTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Elicio Therapeutics

ELTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Elicio Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ELTX

What is the current price of Elicio Therapeutics?

What is the 52-week range for Elicio Therapeutics?

How much debt does Elicio Therapeutics have?

How much cash does Elicio Therapeutics have on hand?

What is Elicio Therapeutics’s dividend yield?

Premium Investing Services